4.8 Article

Regulation of Ferroptotic Cancer Cell Death by GPX4

Journal

CELL
Volume 156, Issue 1-2, Pages 317-331

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2013.12.010

Keywords

-

Funding

  1. NCI's Cancer Target Discovery and Development Network [RC2-CA148399]
  2. Howard Hughes Medical Institute
  3. NIH [5R01-CA70823-15]
  4. US National Institutes of Health [5R01CA097061, 5R01GM085081, R01CA161061]
  5. Arnold and Mabel Beckman Foundation
  6. NYSTAR

Ask authors/readers for more resources

Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown. We sought a common mediator for the lethality of 12 ferroptosisinducing small molecules. We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compounds and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compounds. GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compounds with other lethal mechanisms. In addition, two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models. Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis. Thus, GPX4 is an essential regulator of ferroptotic cancer cell death.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available